These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34529975)

  • 21. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
    Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
    J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
    Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.
    Ohnishi M; Golparian D; Shimuta K; Saika T; Hoshina S; Iwasaku K; Nakayama S; Kitawaki J; Unemo M
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3538-45. PubMed ID: 21576437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
    Shimuta K; Unemo M; Nakayama S; Morita-Ishihara T; Dorin M; Kawahata T; Ohnishi M;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5225-32. PubMed ID: 23939890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic and Genotypic Characterization of
    Jamaludin N; Gedye K; Collins-Emerson J; Benschop J; Nulsen M
    Microb Drug Resist; 2019 Sep; 25(7):1003-1011. PubMed ID: 31021281
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoeae isolates from men who have sex with men.
    Calado J; Castro R; Lopes Â; Campos MJ; Rocha M; Pereira F
    Int J Infect Dis; 2019 Feb; 79():116-122. PubMed ID: 30412735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural effect of the Asp345a insertion in penicillin-binding protein 2 from penicillin-resistant strains of Neisseria gonorrhoeae.
    Fedarovich A; Cook E; Tomberg J; Nicholas RA; Davies C
    Biochemistry; 2014 Dec; 53(48):7596-603. PubMed ID: 25403720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.
    Limnios A; Tapsall J; Kahlmeter J; Hogan T; Ray S; Lam A; Unemo M
    APMIS; 2011 Jun; 119(6):356-63. PubMed ID: 21569093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.
    de Curraize C; Kumanski S; Micaëlo M; Fournet N; La Ruche G; Meunier F; Amarsy R; Jacquier H; Cambau E; Goubard A; Bercot B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6962-6964. PubMed ID: 27600036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain.
    Goire N; Lahra MM; Ohnishi M; Hogan T; Liminios AE; Nissen MD; Sloots TP; Whiley DM
    Euro Surveill; 2013 Apr; 18(14):20444. PubMed ID: 23594520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of ceftriaxone-resistant Neisseria gonorrhoeae strains harbouring a novel mosaic penA gene in China.
    Xiu L; Yuan Q; Li Y; Zhang C; Tang L; Peng J
    J Antimicrob Chemother; 2020 Apr; 75(4):907-910. PubMed ID: 31899504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
    Zhao L; Liu A; Li R; Zhao S
    Int J Antimicrob Agents; 2018 Jan; 51(1):52-56. PubMed ID: 28729124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain.
    Goire N; Ohnishi M; Limnios AE; Lahra MM; Lambert SB; Nimmo GR; Nissen MD; Sloots TP; Whiley DM
    J Antimicrob Chemother; 2012 Apr; 67(4):902-5. PubMed ID: 22207596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct Detection of penA Gene Associated with Ceftriaxone-Resistant Neisseria gonorrhoeae FC428 Strain by Using PCR.
    Whiley DM; Mhango L; Jennison AV; Nimmo G; Lahra MM
    Emerg Infect Dis; 2018 Aug; 24(8):1573-1575. PubMed ID: 30016236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae.
    Takahata S; Senju N; Osaki Y; Yoshida T; Ida T
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3638-45. PubMed ID: 16940068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.
    Zhao S; Duncan M; Tomberg J; Davies C; Unemo M; Nicholas RA
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3744-51. PubMed ID: 19528266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015-2017.
    Shaskolskiy B; Dementieva E; Kandinov I; Filippova M; Petrova N; Plakhova X; Chestkov A; Kubanov A; Deryabin D; Gryadunov D
    PLoS One; 2019; 14(7):e0220339. PubMed ID: 31344102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
    Lee SG; Lee H; Jeong SH; Yong D; Chung GT; Lee YS; Chong Y; Lee K
    J Antimicrob Chemother; 2010 Apr; 65(4):669-75. PubMed ID: 20093260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A real-time PCR assay for detecting a penA mutation associated with ceftriaxone resistance in Neisseria gonorrhoeae.
    Shimuta K; Igawa G; Yasuda M; Deguchi T; Nakayama SI; Ohnishi M
    J Glob Antimicrob Resist; 2019 Dec; 19():46-49. PubMed ID: 30825697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.